ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,699.95
      -0.30%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Roche Holding Ag (0QQ6)

      7. Roche Holding Ag (0QQ6) News

      0QQ6 Roche Holding Ag

      229.20
      0.00 (0.00%)
      May 02 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Roche Holding Ag 0QQ6 London Ordinary Share
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 229.20 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      229.20 229.20
      more quote information »

      Recent News

      Date Time Source Heading
      4/24/202401:00UKREG[Ad hoc announcement pursuant to Art. 53 LR] Roche sales..
      4/24/202401:00UKREG[Ad hoc-Mitteilung gemäss Art. 53 KR] Verkäufe der..
      4/19/202401:00UKREGFDA approves Roche’s Alecensa as the first adjuvant..
      4/17/202402:00UKREGRoche’s subcutaneous OCREVUS one-year data demonstrates..
      4/15/202401:00UKREG[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Columvi..
      4/11/202401:00UKREGRoche granted FDA Breakthrough Device Designation for blood..
      3/26/202412:45UKREGRoche receives FDA approval for the first molecular test to..
      3/12/202408:30UKREGRoche Annual General Meeting 2024
      3/12/202408:30UKREGAssemblée générale 2024 de Roche
      3/12/202408:30UKREGRoche Generalversammlung 2024
      3/05/202407:30UKREGRoche and Alnylam report positive topline results from the..
      2/25/202414:00UKREGNew England Journal of Medicine publishes Phase III data..
      2/16/202411:24UKREGFDA approves Xolair as first and only medicine for children..
      2/01/202401:03UKREGNew long-term data for Roche’s Vabysmo show sustained..
      2/01/202401:00UKREG[Annonce événementielle au sens de l’art. 53 RC] Roche..
      2/01/202401:00UKREG[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds..
      2/01/202401:00UKREG[Ad hoc-Mitteilung gemäss Art. 53 KR] Roche übertrifft..
      1/16/202401:00GLOBEEuropean Commission approves Roche’s Tecentriq SC, the EU's..
      12/29/202316:30GLOBERoche enters into a definitive agreement to acquire..
      12/19/202309:40GLOBEFDA grants priority review to Xolair (omalizumab) for..
      12/15/202301:15GLOBERoche named among top three most sustainable healthcare..
      12/11/202301:00GLOBENew data for Roche’s Columvi and Lunsumio presented at ASH..
      12/09/202311:30GLOBENew data reinforce the benefit of early preventative..
      12/08/202311:50GLOBERoche's Kadcyla is the first targeted therapy to show..
      12/08/202311:45GLOBERoche’s inavolisib combination reduces the risk of disease..
      12/05/202301:00GLOBERoche announces positive Phase III results for inavolisib..
      12/04/202301:00GLOBERoche enters into a definitive merger agreement to acquire..
      11/27/202301:00GLOBERoche expands hepatitis diagnostics portfolio to help..
      11/16/202301:00GLOBERoche launches automated serology hepatitis E virus tests,..
      11/14/202301:00GLOBERoche’s subcutaneous injection of Tecentriq recommended by..
      11/09/202301:00GLOBERoche’s Elecsys NfL test, an important aid for those living..
      10/30/202316:01GLOBE[Ad hoc announcement pursuant to Art. 53 LR] Roche announces..
      10/27/202301:00GLOBE[Ad hoc announcement pursuant to Art. 53 LR] FDA approves..
      10/23/202307:18IHMARKETNEWSMonday’s Wall Street Highlights: Philips, Chevron,..
      10/23/202301:00GLOBE[Ad hoc announcement pursuant to Art. 53 LR] Roche enters..
      10/19/202301:00GLOBE[Ad hoc-Mitteilung gemäss Art. 53 KR] Roche mit gutem..
      10/18/202301:03GLOBERoche IL-6 is the first immunoassay approved to aid sepsis..
      10/18/202301:00GLOBERoche’s Alecensa reduces the risk of disease recurrence or..
      10/13/202309:30GLOBELate-breaking data for Roche’s BTK inhibitor fenebrutinib..
      10/12/202301:00GLOBENew data for Roche’s OCREVUS show that after 10 years of..
      10/11/202302:00GLOBERoche’s OCREVUS twice-yearly, 10-minute subcutaneous..
      10/10/202301:00GLOBERoche’s Vabysmo maintained vision improvements with extended..
      10/04/202301:00GLOBEMajority of newborn babies with spinal muscular atrophy..
      10/02/202301:00GLOBERoche to present new key clinical and real-world data at..
      9/07/202307:00GLOBERoche and Alnylam report positive topline results from Phase..
      9/01/202301:00GLOBERoche’s Alecensa delivers unprecedented Phase III results..
      8/29/202305:00GLOBERoche’s Tecentriq becomes the first subcutaneous..
      8/29/202301:00GLOBEEuropean Commission approves Roche’s Evrysdi for babies..
      8/23/202301:22GLOBE[Ad hoc announcement pursuant to Art. 53 LR] Roche provides..
      7/27/202301:00GLOBE[Ad hoc-Mitteilung gemäss Art. 53 KR] Roche verzeichnet..

      Your Recent History

      LSE
      0QQ6
      Roche
      Delayed Upgrade Clock